Lexicon Pharmaceuticals | 营业费用

股票价格
1.32
每天变化
0.01 0.38%
每月一次
11.44%
每年
89.21%
Q1 预测
2.01


金融业
股票价格
USD
资产
USD 225.58M
现金及等价物
USD 21.36M
销售成本
USD 17.81M
流动资产
USD 145.08M
流动负债
USD 34.84M
债务
USD 99.27M
股息收益率
0
EBIT
USD -49.63M
EBITDA
USD -49.48M
员工
285
EPS每股收益
USD -0.17
股本和储备
USD 129.44M
销售毛利
USD -16.16M
债务利息支出
USD 2.21M
贷款资金
USD 56.11M
市值
USD 322.6M
净收入
USD -53.43M
营业费用
USD 57M
营业利润
USD -55.35M
普通股股本
USD 245K
PE价格收益
12.44
税前利润
USD -53.43M
销售收入
USD 1.65M
销售和管理费用
USD 39.19M
股票
USD 168K
贸易债权人
USD 5.9M
应收帐款人
USD 2.62M


营业费用 更改 日
Abbott USD 9.21B 17M 2025-12
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
Agios Pharmaceuticals USD 129.75M 9.76M 2025-09
Akebia Therapeutics USD 43.82M 16.98M 2025-03
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
AstraZeneca USD 12.53B 4.16B 2025-12
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Coherus Biosciences USD 53.03M 43.41M 2025-03
Eli Lilly USD 10.31B 1.09B 2025-12
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Halozyme Therapeutics USD 136.34M 13.06M 2025-09
Illumina USD 903M 69M 2025-12
Insmed USD 403.69M 42.4M 2025-09
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
J&J USD 18.97B 2.38B 2025-12
Lexicon Pharmaceuticals USD 57M 10.54M 2024-06
MacroGenics USD 67M 8M 2025-09
MannKind USD 63.35M 2.51M 2025-09
Merck USD 10.16B 558M 2025-12
Moderna USD 1.28B 232M 2025-09
Novartis USD 9.86B 115M 2025-09
PTC Therapeutics USD 207.52M 6.21M 2025-09
Puma Biotechnology USD 49.26M 3.2M 2024-06
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Ultragenyx Pharmaceutical USD 330.82M 56.44M 2025-09
United Therapeutics USD 6.59B 6.07B 2025-09
Vanda Pharmaceuticals USD 466M 20.33M 2025-09


Lexicon Pharmaceuticals 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.